Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-820-9 | CAS number: 7757-82-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In a sub-acute oral toxicity study with sodium sulfate no adverse effects were noted. A recent study was to set the NOAEL. This NOAEL (oral, rat) is set at 1000 mg/kg bw/day.
ORAL
Ceccatelli R., 2010 OECD 421 Main Study C79103: The NOAEL 28 d (rat ,oral ) is 1000 mg/kg/day
Moinuddin & Wing-tsit Lee, 1960: the NOAEL 28 d (rat, oral) from this study is 2000 mg/kg/day
DERMAL
Data with respect to repeated dermal toxicity show effects. Male and female New Zealand White Rabbits were treated with the test substance (2 ml/kg/day; 16 % w/w) percutaneously 65 times in 91 days. The only test related effect, which was observed for all groups, was subacute dermatitis that varied from mild to moderate in nature. All other findings were normal or related to spontaneous disease. Some lesions were incidental in nature. LOAEL for the test substance was 2 ml/kg/day (16 % w/w), is 320 mg/kg/day sodium sulphate.
INHALATION
In the available repeated dose study the description of the experiment is insufficient and no actual data are presented. No NOAEL or LOAEL.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Dose descriptor:
- LOAEL
- 320 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Additional information
ORAL, RAT - 28 d
Ceccatelli R., 2010 OECD 421 Main Study C79103: The NOAEL 28 d (rat,oral) is 1000 mg/kg/day
This study is a valid investigation of the toxicological effects resulting from repeated oral-gavage administration of the test item Sodium Sulphate to rats. Sodium Sulphate was administered in highly purified water as vehicle at dosages of 100, 300, and 1000 mg/kg body weight/day, and controls received the vehicle only. Sodium Sulphate was administered to male rats for at least 28 days and to female rats for 14 days prior to pairing, through the pairing and gestation periods until the F1 generation reached day 4 post partum. In absence of any effect the general NOEL (No Observed Effect Level) was established at 1000 mg/kg/day.
Moinuddin & Wing-tstit Lee, 1960: the NOAEL 28 d (rat, oral) from this study is 2000 mg/kg/day
NOAEL (NOEL:) The oral administration of sodium sulfate to rats by dietary admixture for a period of 4 weeks at a dose level of 0.88 mmol/kg feed did not result in any effects. A dosing regime of 8.64 mmol/kg feed on days 1-8, 17.28 mmol/kg feed on days 9-16, 34.56 mmol/kg feed on days 17-24 and 65.12 mmol/kg feed from day 25 for 4-6 days resulted in two slight cases of diarrhea that lasted for a day. At a dose level of 138 mmol/kg feed one rat showed diarrhea on 4 different days (3 consecutive days) in the middle of the feeding period. At the top dose the food contained around 2% sodium sulfate based on which the NOAEL was calculated to be around 2000 mg/kg bw/day.
ORAL, RAT - 28 d and 27/44 week
A clear NOAEL cannot be derived from the available data. In the study of Blunck and Crowter (1975), refer to Carcinogenicity [7757 -82 -6 Carcinogenicity, Blunck, J.M. et al., (1975)] two groups of 5 male rats were fed 21% sodium sulphate in the diet for 27 and 44 weeks respectively. No adverse effects were detected with respect to the limited number of endpoints reported from this study. Obviously, group size is too limited to draw firm conclusions but tentatively a chronic NOAEL of >= 320 mg/kg/day may be deduced from a 27 / 44-week study and a sub-chronic NOAEL of 2000 mg/kg from a 28 day study in rats. Ruminating animals are at risk at much lower levels because of the potential formation of sulfide in the rumen. Since this substance has no discernable systemic toxicity, the tentative chronic NOAEL of >= 320 mg/kg in rats would seem to provide a reasonable margin of safety compared to the estimated daily intake of 453 mg/person/day or around 6.5 to 7.5 mg/kg/day.
DERMAL
In a 91-Day Percutaneous Toxicity Study (1977) the rabbit skin appeared normal in all groups. A statistically significant (P0.05) increase in MCV and MCH values was noted for the females in the test substance group as compared to the vehicle control females. This increase did not appear to be biologically significant since all individual values were within a normal range for rabbits. The only test-related lesion observed was a subacute dermatitis. 3 animals in the vehicle control group had mild subacute dermatitis. 8 animals in the test substance group had subacute dermatitis that varied from mild to moderate in nature. All other findings were normal or related to spontaneous disease. Some lesions were incidental in nature.
Based on the results of the study, the LOAEL for the test substance was 2 ml/kg/day (16 % w/w) = 320 mg/kg/day sodium sulphate.
INHALATION
In a 90 -day study of Denisov et al (1989, 1990) in which rats were exposed to 1 mg/m3 sodium sulfate together with 500 mg/l in drinking water, i.e an estimated dose of 60 mg/kg/d orally and 0.6 mg/kg/day by inhalation. Apart from the neuro-physiological and biochemical parameters described, body weight was also depressed, relative liver weight was decreased, histopathological evidence of serious lung damage and testicular damage was described. The description of the experiment is insufficient, and no actual data are presented. No NOAEL or LOAEL.
Based on the results of several acute toxicity inhalation studies it is unlikely that inhalation of respirable sodium sulfate particles causes pulmonary irritation or systemic effects
Justification for classification or non-classification
Sodium sulphate is not classified based on the test results obtained from the two subacute toxicity studies (28 day, oral, rat), a sub-chronic toxicity study (27/44 week, oral, rat).
Based on the LOAEL of a dermal sub-chronic toxicity study (90 day, dermal, rat) sodium sulphate should not be classified.
Based on the results of the oral and dermal repeated dose toxicity study, sodium sulfate does not need to be classified for repeated dose toxicity according to EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.